Build your own keyword analysis with our tools
SEO Report
Server Infos
Backlinks

HTML Analysis

Page Status
 

Found

Highlighted Content
Title

Astex Pharmaceuticals | Oncology Drug Discovery & Development

Description

Astex Pharmaceuticals is a global leader in oncology drug discovery and development through partnerships with leading pharmaceutical companies.

Keywords

oncology drug discovery and development

H1

H2

product pipeline
receive investor updates

H3

8th World Congress of Melanoma
Sixth Joint Sheffield Conference on...
SGI110 – DNMT inhibitor (MDS, AML, Ovarian & Liver)
AT7519 – CDK inhibitor (MM)
Amuvatinib/MP470 (SCLC)
AT13387 – HSP90 inhibitor (GIST, Prostate & Lung)

H4

NASDAQ:
ASTX:
Corporate Partnerships

H5

Text Analysis

Cloud of Keywords from all content
High relevance
 

Medium relevance
 

clinical phase inhibitor pharmaceuticals

Low relevance
 

inhibitor pharmaceuticals partnering july astex nasdaq dublin corporate

Very Low relevance
 
partnering july astex nasdaq dublin corporate gist sclc trial at13387 cdk hsp90 mp470 trial amuvatinib liver dnmt pipeline sgi110 product mds aml prostate ovarian trial at7519 products statement site forward-looking reserved rights map privacy policy terms suite blvd use astex partnerships alerts receive events pipeline investor updates get updates financial automatic trial see joint platform publications pyramid™ events presentations trials scientific astexviewer&trade partnering intellectual information corporate calendar stock property events board careers products clinical advisory discovery drug oncology development astx team scientific values leadership about pipeline technology partners investors contact mission governance board committees sec congress 8th 17-20 melanoma 22-24 conference sheffield sixth service clipping faqs annual releases investor filings press reports investor kit email events press news upcoming alerts in scientific

Highlighted Content Analysis

Cloud of Keywords from all content
High relevance
 

Medium relevance
 

inhibitor &ndash

Low relevance
 

inhibitor &ndash astex partnerships development pharmaceuticals discovery oncology drug

Very Low relevance
 
astex partnerships development pharmaceuticals discovery oncology drug liver at7519 cdk mds amuvatinib aml ovarian gist astx corporate oncology drug discovery and development nasdaq prostate sclc at13387 hsp90 mp470 sheffield product pipeline receive companies pharmaceutical global leader leading investor updates joint conference sgi110 sixth melanoma 8th congress dnmt